总时间（秒）：14.62
问答时间（秒）：12.08

Here is the JSON object with the requested information for the variant C289G in Parkin:

```json
{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "G",
          "position": "289"
        },
        "variant_string_id": "PARK2 C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson’s disease is the most common neurodegenerative movement disorder. It is characterized clinically by bradykinesia, resting tremor, rigidity and postural instability. Its pathological features include the progressive degeneration of dopaminergic neurons in the midbrain substantia nigra pars compacta and the formation of intracytoplasmic inclusions called Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Parkin contains an N-terminal ubiquitin-like domain (Ubl) and two C-terminal RING domains. It functions as a ubiquitin–protein ligase...",
          "judgment": "Yes",
          "reasoning": "The general class of assay used for this variant (ubiquitin–protein ligase activity assay) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Parkin(C289G) aggregation and inclusion formation were suppressed by the neuronal DnaJ/Hsp40 chaperone HSJ1a(DNAJB2a). Importantly, HSJ1a and DNAJB6 also restored mitophagy by promoting the relocation of Parkin(C289G) and the autophagy marker LC3 to depolarized mitochondria.",
          "judgment": "No",
          "reasoning": "The specific instance of the assay (mitophagy assay) has not been broadly accepted historically or previously validated in other studies. No controls/replicates are documented for the specific instance of the assay in this paper."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Parkin(C289G) fails to redistribute to damaged mitochondria and cannot induce mitophagy after treatment with the mitochondrial uncoupler carbonyl cyanide m-methylhydrazone, because of protein misfolding and aggregation.",
          "judgment": "No",
          "reasoning": "The statistical analyses in the paper are insufficient to estimate or calculate OddsPath for the functional data for this variant."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Parkin(C289G) aggregation and inclusion formation were suppressed by the neuronal DnaJ/Hsp40 chaperone HSJ1a(DNAJB2a). Importantly, HSJ1a and DNAJB6 also restored mitophagy by promoting the relocation of Parkin(C289G) and the autophagy marker LC3 to depolarized mitochondria.",
          "judgment": "No",
          "reasoning": "At least 11 total benign/pathogenic variant controls were used across the entire study (as applicable to this variant’s assay)."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "N/A"
      },
      "overall_conclusion": "The functional evidence strength for PARK2 C289G is N/A because it does not meet the criteria for PS3/BS3 classification in any step of the ACMG flowchart."
    }
  ]
}
```

In conclusion, based on the extracted information and the application of the ACMG flowchart, the final evidence strength for PARK2 C289G is "N/A" (Not Applicable).